Biotech · Private company · Waltham, MA, US
Deciphera Pharmaceuticals, Inc.
SEC CIK 0001654151
Track this companyFree. Adds Deciphera Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2312 recruiting or active
Pipeline programs27From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline27
- DCC-2618Phase 3 · Gastrointestinal Stromal TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RipretinibPhase 3 · GISTClinicalTrials.gov · fetched Nov 12, 2026
- RipretinibPhase 3 · Gastrointestinal Stromal TumorsClinicalTrials.gov · fetched Nov 12, 2026
- SunitinibPhase 3 · GISTClinicalTrials.gov · fetched Nov 12, 2026
- SunitinibPhase 3 · Gastrointestinal Stromal TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VimseltinibPhase 3 · Tenosynovial Giant Cell TumorClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Locally Advanced or Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DCC-3009Phase 2 · Gastrointestinal Stromal Tumor (GIST)ClinicalTrials.gov · fetched Nov 12, 2026
- InlexisertibPhase 2 · GISTClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Locally Advanced or Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RebastinibPhase 2 · Locally Advanced or Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- VimseltinibPhase 2 · Advanced Malignant NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- VimseltinibPhase 2 · Chronic Graft-Versus-Host Disease (cGVHD)ClinicalTrials.gov · fetched Nov 12, 2026
- BinimetinibPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Combined Oral Contraceptive (COC) (ethinyl estradiol [EE]/levonorgestrel [LNG])Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- DabigatranPhase 1 · Healthy Male ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- DCC-2812Phase 1 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- DCC-3084Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- InlexisertibPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- RepaglinidePhase 1 · GIST - Gastrointestinal Stromal TumorClinicalTrials.gov · fetched Nov 12, 2026
- RipretinibPhase 1 · GIST - Gastrointestinal Stromal TumorClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrametinibPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- VimseltinibPhase 1 · Healthy Male ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- VimseltinibPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male ParticipantsPHASE1 · RECRUITING · started Oct 8, 2026ClinicalTrials.gov NCT07744802 · fetched Nov 12, 2026
- IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)PHASE3 · RECRUITING · started Jun 12, 2026ClinicalTrials.gov NCT07104032 · fetched Nov 12, 2026
- Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)PHASE1 · COMPLETED · started Jun 5, 2026ClinicalTrials.gov NCT07539090 · fetched Nov 12, 2026
- INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)PHASE3 · RECRUITING · started May 25, 2026ClinicalTrials.gov NCT07429266 · fetched Nov 12, 2026
- Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)PHASE1 · COMPLETED · started Nov 20, 2025ClinicalTrials.gov NCT07158411 · fetched Nov 12, 2026
- Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 SubstratePHASE1 · COMPLETED · started Oct 31, 2025ClinicalTrials.gov NCT07158398 · fetched Nov 12, 2026
- MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With VimseltinibRECRUITING · started Sep 3, 2025ClinicalTrials.gov NCT07075471 · fetched Nov 12, 2026
- Study of DCC-2812 in Participants With Advanced Genitourinary CancersPHASE1 · RECRUITING · started Aug 27, 2025ClinicalTrials.gov NCT06966024 · fetched Nov 12, 2026
- A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)PHASE1_PHASE2 · RECRUITING · started Dec 10, 2024ClinicalTrials.gov NCT06630234 · fetched Nov 12, 2026
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)PHASE2 · RECRUITING · started Nov 21, 2024ClinicalTrials.gov NCT06619561 · fetched Nov 12, 2026
- Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) PathwayPHASE1 · TERMINATED · started May 14, 2024ClinicalTrials.gov NCT06287463 · fetched Nov 12, 2026
- A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With ImatinibPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 13, 2023ClinicalTrials.gov NCT05734105 · fetched Nov 12, 2026
- A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 28, 2023ClinicalTrials.gov NCT05957367 · fetched Nov 12, 2026
- Study of Vimseltinib for Tenosynovial Giant Cell TumorPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 14, 2021ClinicalTrials.gov NCT05059262 · fetched Nov 12, 2026
- A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GISTPHASE1 · COMPLETED · started Sep 22, 2021ClinicalTrials.gov NCT04530981 · fetched Nov 12, 2026
- Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsPHASE1 · TERMINATED · started Jun 15, 2021ClinicalTrials.gov NCT04892017 · fetched Nov 12, 2026
- A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 8, 2019ClinicalTrials.gov NCT03673501 · fetched Nov 12, 2026
- A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jan 2, 2019ClinicalTrials.gov NCT03717415 · fetched Nov 12, 2026
- A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · TERMINATED · started Oct 25, 2018ClinicalTrials.gov NCT03601897 · fetched Nov 12, 2026
- Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer TherapiesPHASE3 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03353753 · fetched Nov 12, 2026
- Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell TumorPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 16, 2017ClinicalTrials.gov NCT03069469 · fetched Nov 12, 2026
- Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast CancerPHASE1 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02824575 · fetched Nov 12, 2026
- A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesPHASE1 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02571036 · fetched Nov 12, 2026